207_Combined course Presentations

Risk of Secondary breast cancer (from GHSG trial)

 5804 early stage HL patients (GHSG trial HD7-HD8-HD10-HD11-HD14)  Median age: 34 years  Female patients: 48%

RT volume not involving breasts

Age > 30

males

100 HL patients

15 received

RT dose to the breasts

48 females

22 Age ≤30

RT-induced Breast Cancers at 30 years: 2-3 cases (15-20%)